| NCT ID | NCT06641531 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Cervix Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-10-01 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.
Eligibility Criteria
Inclusion Criteria: * Non pregnant sexually active women aged from 21 to 60 years old. * Patients who didn't have their pap smear done in last 3 years . * Patient who had previous abnormal pap smear and coming for follow up. Exclusion Criteria: * Women who were diagnosed cervical cancer that was treated. * Women who underwent total hysterectomy. * Women who are pregnant. * Patients whose pap smear was done in last 3 years with reassuring results.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06641531 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 60 Years, studying Cervix Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06641531 currently recruiting?
Yes, NCT06641531 is actively recruiting participants. Contact the research team at mostafa_redwan_post@med.sohag.edu.eg for enrollment information.
Where is the NCT06641531 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06641531 clinical trial?
NCT06641531 is sponsored by Sohag University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.